Zenith Drugs Limited - Due diligence report

A 360° intelligence report on Zenith Drugs Limited: trust score, financial health, credit view, compliance, directors, growth and distress s…

2000-11-15 Depalpur, Madhya Pradesh Active Listed Active Compliant
Share
View plans
ZD Zenith Drugs Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Zenith Drugs Limited — 360° Intelligence Report

Generated from MCA filings & public records
80/100
Trust Score
Low Risk

Zenith Drugs Limited is assessed as Low Risk with a Trust Score of 80/100. Zenith Drugs Limited is an active public limited indian non-government company incorporated in 2000, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 28 Jun 2026 from the latest processed filings. Zenith Drugs Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
80/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
78/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
85/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
65/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreCaution Indicated
45/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
80/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 65/100 Moderate
  • Open charges exceed net worth - secured lenders rank ahead.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.
  • Externally credit-rated (BB-).

Charges position: 11 open (110.89 cr) · 11 satisfied (109.84 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Sbicap Trustee Company Limited1 48.0 cr
State Bank Of India1 48.0 cr
Others5 48.0 cr
Hdfc Bank Limited3 48.0 cr
Sidbi6 48.0 cr
The Madhya Pradesh Financial Corporation3 48.0 cr
Compliance Score: 78/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Litigation present in 2 court forum(s).
  • Delayed payments to MSME suppliers disclosed (214 disclosure(s)).
  • 4 active GST registration(s).
Legal cases on record (2)
05

Director Intelligence

Stability score: 45/100
NameDIN / PANDesignationAppointedTenureDIN status
DEENDAYAL KUMAWAT 01234567 Director 01/04/2018 6 yrs Approved
AJAY SINGH DASSUNDI 01234567 Director 01/04/2018 6 yrs Approved
ANIL MALIK 01234567 Director 01/04/2018 6 yrs Approved
BHUPESH SONI 01234567 Director 01/04/2018 6 yrs Approved
SANDEEP BHARDWAJ 01234567 Director 01/04/2018 6 yrs Approved
RANJANA SEHGAL 01234567 Director 01/04/2018 6 yrs Approved
Neeraj Pandey 01234567 Director 01/04/2018 6 yrs Approved
Rajesh Agrawal 01234567 Director 01/04/2018 6 yrs Approved
  • 8 directors on the board.
  • ANIL MALIK has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • 1 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
1
Group entities
1
Capital events
-

Key managerial personnel: SANDEEP BHARDWAJ (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 80 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +38% over 4 year(s).
Asset base grew 1.42 - capacity expansion.
EPFO headcount growing - hiring signal.
Operating for 25+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
11 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 2.02 cr.
2 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence82/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment74/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 11 open charge(s) of 110.89 cr already registered.
  • Compliance record supports lending.
Investor view82/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 15 events
13 Dec 2025
Director appointed
Rajesh Agrawal (Cfo)
29 Sep 2025
Last AGM held
Annual general meeting
22 Sep 2025
Charge created
Sidbi - 92.00 Lakh
31 Mar 2025
Latest balance sheet
Filed with ROC
26 Mar 2025
Charge created
Sidbi - 2.03 cr
20 Mar 2025
Charge satisfied
State Bank Of India
10 Mar 2025
Charge created
Sbicap Trustee Company Limited - 76.98 cr
07 Mar 2025
Charge satisfied
Others
19 Oct 2024
Charge created
State Bank Of India - 75.15 cr
17 Oct 2024
Charge created
Others - 51.86 Lakh
28 Sep 2024
Director appointed
Neeraj Pandey (Cfo)
26 Jun 2024
Charge created
Sidbi - 75.00 Lakh
25 Sep 2023
Director appointed
DEENDAYAL KUMAWAT (Director)
Director appointed
ANIL MALIK (Director)
16 Sep 2023
Director appointed
RANJANA SEHGAL (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Debt-to-equity stands at 61% - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
8 active director(s) / partner(s); review board churn before relying on management continuity.
4 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 1 subsidiary(ies) - assess on a consolidated basis.
Carries an external credit rating of BB- from Crisil.
EPFO-registered employer - verifiable payroll history exists.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Bhoruka Specialty Gases Private Limited U40107KA2022PTC164179 Bangalore, Karnataka, India
Shalimar Incense Private Limited U74999KA2018PTC109782 Bangalore, Karnataka, India
Corvine Chemicals U85110KA1992PTC013271 Bidar, Karnataka, India
Alpa Labs L85195MP1988PLC004446 Indore, Madhya Pradesh, India
Lyka Labs L24230GJ1976PLC008738 Ankleshwar, Gujarat, India
Insecticides L65991DL1996PLC083909 Delhi, Delhi, India
K Rasiklal Exim Private Limited U51900MH2000PTC128614 Mumbai, Maharashtra, India
Murli Krishna Pharma U24230PN2004PTC206917 Pune, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Zenith Drugs Limited before audits and certifications: compliance score 78/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Zenith Drugs Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 65/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 80/100, margin trends, ownership structure and peer set for Zenith Drugs Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 80/100, distress signals and MSME payment-delay disclosures - know whether Zenith Drugs Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Zenith Drugs Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Zenith Drugs Limited an active company?

Zenith Drugs Limited has MCA status “Active” with a compliance score of 78/100 (Low Risk).

Is Zenith Drugs Limited financially healthy?

Zenith Drugs Limited has a Financial Health Score of 85/100 (Low Risk) based on its filed financial statements.

Should I do business with Zenith Drugs Limited?

Its overall Trust Score is 80/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Zenith Drugs Limited?

See the directors and ownership sections above for board and shareholding detail. 8 active director(s) are on record.

Does Zenith Drugs Limited have loans or charges against its assets?

11 open charge(s) are registered against its assets, and 11 earlier charge(s) stand satisfied.

Is Zenith Drugs Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 78/100 (Low Risk).

Is it risky to lend to Zenith Drugs Limited?

Its Credit Risk Score is 65/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.